February 28, 2023
28/02/2023
February 28, 2023
LA JOLLA, CA The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has awarded scientists at Scripps Research a $10 million grant to study the cellular and molecular changes in the brain that underlie alcohol use disorder (AUD). The grant will fund the Scripps Research Alcohol Research Center (TSRI-ARC) for five years, carrying the research into its 50th year of consecutive NIAAA funding first beginning in 1977.
A lot of exciting things have happened in the AUD field over the last 45 years, and the center has been at the forefront of many of them, says TSRI-ARC Director Barbara Mason, PhD, the Pearson Family Chair and Director of the Pearson Center For Alcoholism and Addiction Research at Scripps Research. But there is a lot of work still to be done, so it is incredibly gratifying to receive more funding that extends the lifetime of this grant to 50 years. We're bringing together an unusually wide-ranging group of experts to bear on understanding alcohol use disorder and the challenge of treating it.
Funding the future of AUD research
The grant will fund five separate research components led by associate professor Candice Contet, PhD (Molecular), UC San Diego professor Olivier George, PhD (Functional Connectomics), associate professor R mi Martin-Fardon, PhD (Neurochemistry), Schimmel Family Chair and Vice Chair Marisa Roberto, PhD (Neurophysiology), and associate professor Eric Zorrilla, PhD (Neurocircuitry); and two resource cores led by senior scientific director Amanda Roberts, PhD (Animal Models), and Ernest W. Hahn Professor John Yates III, PhD (Neuroproteomics).
The funding also includes support for heightening interest in AUD research by providing high school and college internships for students in high-risk, underserved communities. TSRI-ARC is the only NIAAA-funded alcohol research center south of Los Angeles, and center members make an effort to share their expertise and resources with other institutions throughout the greater San Diego area. The projects funded by the grant include researchers not only at Scripps Research, but also collaborators at the UC San Diego (UCSD).
Built on a rich history
The Alcohol Research Center at Scripps Research was first funded under the leadership of Floyd Bloom, MD, chairman emeritus of neuropharmacology. Over the early decades of NIAAA funding, Bloom and others at TSRI-ARC were responsible for highlighting the importance of changes in brain neurocircuits as drivers of alcohol misuse. The center also discovered the role of stress neurocircuits in negative reinforcement in alcohol addiction and dependence. Multiple studies have subsequently revealed that the negative feelings associated with protracted withdrawal from alcohol are just as important in spurring addiction as the positive feelings associated with alcohol consumption.
People used to think that alcohol use disorder was really an indication of flawed willpower, says Mason. Our work here at Scripps Research over the years has gone a long way in changing that perception by identifying the neurocircuits and molecules that are involved in driving this disorder.
With the newest grant renewal, Mason and colleagues will be expanding their focus to include a set of cellular and molecular mechanisms in the brain that normally limit compulsive behavior. The research team wants to know specifically what happens to impair these executive function control mechanisms in people with AUD. They hypothesize that stress systems in the brain can impair these control mechanisms and make people more susceptible to developing AUD, or more susceptible to drinking relapse. The renewal funds will help the researchers test these foundational hypotheses and identify potential novel treatment strategies for AUD.
Of note, some of the findings from TSRI-ARC have led to clinical trials of drugs that may eventually be used to treat AUD. For instance, early work by Bloom on the importance of the brain signaling molecule known as hypocretin or orexin contributed to more recent basic research and clinical trials at Scripps Research on drugs targeting this system to treat AUD. And a 2014 trial, led by Mason, indicated the efficacy of the existing epilepsy drug gabapentin in treating AUD and contributed to the inclusion of gabapentin in new practice guidelines for AUD treatment.
A critical moment in time
According to the NIAAA, an estimated 29.5 million people in the United States have AUD, a chronic brain disorder characterized by compulsive drinking, loss of control over alcohol use and negative emotions when not drinking. Nearly 100,000 people die from alcohol-related causes annually, and alcohol misuse has been calculated to cost the United States economy $249 billion per year.
Mason emphasizes that now is a vital time to continue research into the underlying causes of AUD. Alcohol misuse and its untoward effects have risen in recent years, with the COVID-19 pandemic driving a new spike in rates of AUD. At the same time, organizations such as the American Psychiatric Association are embracing new and existing pharmacological treatments for AUD and issuing new guidelines on treating the disorder.
The tide is turning, but there still haven't been any FDA-approved treatments for AUD in nearly two decades, says Mason. Our primary goal with this grant renewal is to answer basic science questions about AUD and evaluate our discoveries for their potential translation into novel treatments for AUD.
Molecular Medicine Mason, Barbara
LINK: | https://www.scripps.edu/news-and-events/press-room/2023/20230228-mason... |
See more stories from scripps |
More from Scripps
20/04/2024
April 19, 2024
New copper-catalyzed C-H activation strategy from Scripps Research Two-mode reactions inspired by human detox enzymes offer powerful new tools for drug discover...
12/04/2024
April 11, 2024
Scripps Research chemists devise easier new method for making a common type of building block for drugs Scientists transform simple linear amines into saturated...
06/04/2024
April 05, 2024
A simple, inexpensive way to make carbon atoms bind together A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules,...
04/04/2024
April 03, 2024
Developing a vaccine for the zombie drug xylazine Scripps Research chemical biologists design an early proof-of-concept vaccine that could lead to the first...
30/03/2024
March 29, 2024
How blocking a neural receptor responsible for addiction could reduce alcohol use A Scripps Research team found that a new therapeutic that targets the kappa op...
13/03/2024
March 13, 2024
New computational strategy boosts the ability of drug designers to target proteins inside the membrane Customized-design approach could streamline the design of...
29/02/2024
February 29, 2024
Scripps Research scientists reveal how first cells could have formed on Earth New phospholipid discovery brings researchers closer to understanding how primordi...
29/02/2024
February 28, 2024
How molecular handedness emerged in early biology Scripps Research chemists fill a major gap in origin-of-life theories. February 28, 2024 LA JOLLA, CA Mole...
22/02/2024
February 21, 2024
Snaking toward a universal antivenom Scripps Research scientists discovered antibodies that protect against a host of lethal snake venoms. February 21, 2024 ...
06/02/2024
February 06, 2024
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases AbbVie...
26/01/2024
January 25, 2024
Re-energizing mitochondria to treat Alzheimer's disease Scripps Research team restored neuron-to-neuron connections in human cells. January 25, 2024 LA JO...
24/01/2024
January 04, 2024
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health For the last century, institute leaders and renowned scie...
23/01/2024
January 23, 2024
New technology lets researchers track brain cells' off switches The method could shed light on what goes awry in numerous brain conditions when neurons ar...
09/01/2024
January 08, 2024
Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines The ALSAM Foundation, founded by the Skaggs family, provides lasting g...
04/01/2024
January 03, 2024
Life science entrepreneur Gene Lay joins Scripps Research Board of Directors Lay, founder of the global biotech company BioLegend, brings invaluable experience ...
21/12/2023
December 20, 2023
Taming a plant-derived toxin Scripps Research team modifies the traditional poison picrotoxinin for potential neurological drugs and anti-parasite treatments. ...
19/12/2023
December 18, 2023
Scripps Research Executive Vice President Eric Topol gives TED talk on transformative power of AI in medicine Topol provides an overview of how AI models can i...
13/12/2023
December 12, 2023
New AI-powered algorithm could better assess people's risk of common heart condition Early detection of atrial fibrillation can reduce the risk of stroke an...
07/12/2023
December 06, 2023
Nanoparticle flu vaccine design shows promise in early tests Scripps Research-designed vaccine could provide broad, enduring protection against influenza A str...
16/11/2023
November 15, 2023
Numerous Scripps Research scientists named Highly Cited Researchers Clarivate's annual, global list represents researchers who have demonstrated significant...
07/11/2023
November 06, 2023
Multiple sclerosis drug invented at Scripps Research slows long-term devastating disease progression Late-breaking data reinforces the effectiveness and safety ...
05/10/2023
October 04, 2023
Keren Lasker named a 2023 Moore Inventor Fellow The prestigious award will support Lasker's inventive research in membraneless organelles and their applica...
22/09/2023
September 21, 2023
Michael Bollong named a 2023 Amgen Young Investigator The prestigious award will support Bollong's research identifying new molecular targets and therapeuti...
09/09/2023
September 08, 2023
Philip Dawson receives 2024 American Chemical Society National Award Dawson is honored with the Arthur C. Cope Late Careers Scholar Award for his foundational c...
07/09/2023
September 06, 2023
Scripps Research chemists devise a method for C-H activation of alcohols The method represents a new toolkit for making drugs and other compounds. September 06...
31/08/2023
August 30, 2023
Scripps Research receives $1.5M to surveil infectious disease threats in wastewater Bill & Melinda Gates Foundation award to support the development of multi-pa...
16/08/2023
August 16, 2023
How cold temperatures trigger the brain to boost appetite Scripps Research scientists' discovery could lead to new weight loss and metabolic health treatmen...
08/08/2023
August 07, 2023
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study Scripps Research-developed antibody therapy...
04/08/2023
August 03, 2023
How sensory neurons impact the gut Scripps Research scientists show that the receptor PIEZO2 in sensory neurons controls gut motility and transit time, which a...
26/07/2023
July 26, 2023
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets The expanded strategic collaboration will advan...
23/07/2023
July 21, 2023
Scripps Research scientists develop AI-based tracking and early-warning system for viral pandemics Machine-learning system effectively predicts emergence of pro...
19/07/2023
July 19, 2023
Monitoring T cells may allow prevention of type 1 diabetes Scripps Research study shows that analyzing T cells in blood samples could be used to select at-risk ...
19/07/2023
July 18, 2023
Scripps Research mourns passing of leading organic chemist Albert Eschenmoser Eschenmoser pioneered key reactions in synthetic chemistry and shaped the understa...
15/06/2023
June 14, 2023
Scripps Research awarded $46.8 million by NIH to promote human health through innovative translational science and training The Translational Institute is harne...
13/06/2023
June 13, 2023
Scripps Research's Danielle Grotjahn named 2023 Pew Scholar in the Biomedical Sciences The award will support Grotjahn's study of how cells assemble the...
31/05/2023
May 31, 2023
Crossing the ring: new method enables C-H activation across saturated carbocycles Scripps Research chemists add another powerful tool to their molecular editin...
24/05/2023
May 23, 2023
Scripps Research develops behind-the-scenes tool for better biomedical data discovery The new resource makes datasets more discoverable for life science communi...
19/05/2023
May 15, 2023
Scripps Research neuroscientist Hollis Cline elected to American Academy of Arts and Sciences Cline is recognized for her discoveries about the role of sensory ...
19/05/2023
May 18, 2023
Scripps Research's Skaggs Graduate School awards doctoral degrees to 31st graduating class Commencement ceremony will be livestreamed via Zoom and on instit...
13/05/2023
May 12, 2023
A better route to benzocyclobutenes, sought-after building blocks for drugs Scripps Research chemists devise a new, C-H activation-based method for the synthesi...
09/05/2023
May 08, 2023
Renowned Scripps Research professor Jeffery Kelly elected to National Academy of Sciences Kelly's groundbreaking work on protein misfolding has led to thera...
28/04/2023
April 27, 2023
Mirror-image molecules pave new path for cancer drug discovery By comparing how mirror image versions of small molecules impact clusters of proteins, Scripps R...
22/04/2023
April 21, 2023
How alcohol consumption contributes to chronic pain A Scripps Research team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and...
21/04/2023
April 20, 2023
Xin Jin receives dual awards to study autism risk genes in neurodevelopment Major grants from the National Institutes of Health and California Institute for Reg...
20/04/2023
April 19, 2023
Trim the sugar: New HIV vaccine design improves immune response Scripps Research vaccine candidate headed for clinical trials. April 19, 2023 LA JOLLA, CA A...
18/04/2023
April 17, 2023
Therapeutic can seek and destroy potent opioid to treat overdoses Scripps Research chemists developed a new biologic to work against the synthetic opioid carfen...
07/03/2023
March 06, 2023
How heavy alcohol consumption increases brain inflammation The findings by a Scripps Research team point toward a potential new drug target for treating alcohol...
02/03/2023
March 01, 2023
Scientists find human antibodies that can block multiple coronaviruses including SARS-CoV-2 Results from a Scripps Research and UNC team pave the way for a vacc...
28/02/2023
February 28, 2023
$10 million grant funds Scripps Research Alcohol Research Center through its 50th year The five-year grant supports research into the neurobiology of alcohol us...
28/02/2023
February 27, 2023
Immune system drug shows promise in treating alcohol use disorder, a Scripps Research clinical trial reports Scientists at Scripps Research found that apremilas...